Mortality risk factors for bloodstream infections caused by extended-spectrum beta-lactamase-producing microorganisms

被引:10
作者
Ferrandez, O. [1 ]
Grau, S. [1 ]
Saballs, P. [1 ]
Luque, S. [1 ]
Terradas, R. [1 ]
Salas, E. [1 ]
机构
[1] Hosp del Mar, Barcelona, Spain
来源
REVISTA CLINICA ESPANOLA | 2011年 / 211卷 / 03期
关键词
Bacteremia; Extended-spectrum beta-lactamases; Mortality risk factor; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; ANTIMICROBIAL TREATMENT; CLINICAL-OUTCOMES; THERAPY; ENTEROBACTERIACEAE; BACTEREMIA; PREDICTORS; RESISTANCE;
D O I
10.1016/j.rce.2010.05.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To identify risk factors for mortality in patients with bloodstream infection by extended-spectrum beta-lactamase (ESBL)-producing microorganisms. Material and methods: A retrospective study in patients with bloodstream infection by ESBL-producing microorganisms from January 2000 to December 2006 was carried out. Results: A total of 4,172 bloodstream infections were identified, 1,218 (29.2%) and 226 (5.4%) of which were caused by Escherichia coli and Klebsiella pneumoniae, respectively. The overall mortality rate was 50.9% in patients with bacteriema due to ESBL-producing strains. The binomial logistic regression model, adjusted for age and severity, identified admission to an intensive care unit (OR 38,631; 95%CI:3,375-424,618; P = .002) and a SAPS II severity index score >30 in the 24-48 h before obtaining blood culture (OR 17,980; 95% CI:2,193-170,439; P = .010) as factors associated to mortality, while the urinary tract as primary site of infection was an independent determinant for non-mortality (OR 0.184; 95% 0:0.034-0.975; P = .047). Conclusions: Patients with suspicion of bacteriema who have been admitted to the ICU with a score of elevated severity should be candidates for early empirical treatments as they have a greater risk of mortality. However, the benefit of this strategy may be limited due to the baseline severity of the patient. (C) 2011 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:119 / 126
页数:8
相关论文
共 23 条
[1]   Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae [J].
Anderson, DJ ;
Engemann, JJ ;
Harrell, LJ ;
Carmeli, Y ;
Reller, LB ;
Kaye, KS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (05) :1715-1720
[2]   Clinical significance of healthcare-associated infections in community-onset Escherichia coli bacteraemia [J].
Cheong, Hae Suk ;
Kang, Cheol-In ;
Kwon, Ki Tae ;
Heo, Sang Tack ;
Wi, Yu Mi ;
Kim, Eun Seok ;
Lee, Jin Seo ;
Ko, Kwan Soo ;
Chung, Doo Ryeon ;
Lee, Nam Yong ;
Song, Jae-Hoon ;
Peck, Kyong Ran .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (06) :1355-1360
[3]  
CLSI, 2010, M10020 CLSI
[4]   In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum β-lactamase [J].
Elliott, E ;
Brink, AJ ;
van Greune, J ;
Els, Z ;
Woodford, N ;
Turton, J ;
Warner, M ;
Livermore, DM .
CLINICAL INFECTIOUS DISEASES, 2006, 42 (11) :E95-E98
[5]   Health care-associated bloodstream infections in adults: A reason to change the accepted definition of community-acquired infections [J].
Friedman, ND ;
Kaye, KS ;
Stout, JE ;
McGarry, SA ;
Trivette, SL ;
Briggs, JP ;
Lamm, W ;
Clark, C ;
MacFarquhar, J ;
Walton, AL ;
Reller, LB ;
Sexton, DJ .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (10) :791-797
[6]   CDC DEFINITIONS FOR NOSOCOMIAL INFECTIONS, 1988 [J].
GARNER, JS ;
JARVIS, WR ;
EMORI, TG ;
HORAN, TC ;
HUGHES, JM .
AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (03) :128-140
[7]   Escherichia coli:: Development of carbapenem resistance during therapy [J].
Hong, T ;
Moland, ES ;
Abdalhamid, B ;
Hanson, ND ;
Wang, J ;
Sloan, C ;
Fabian, D ;
Faraiallah, A ;
Levine, J ;
Thomson, KS .
CLINICAL INFECTIOUS DISEASES, 2005, 40 (10) :E84-E86
[8]  
HUTSON PR, 2004, BASIC SKILLS INTERPR, P441
[9]   Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae -: Variability by site of infection [J].
Hyle, EP ;
Lipworth, AD ;
Zaoutis, TE ;
Nachamkin, I ;
Bilker, WB ;
Lautenbach, E .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (12) :1375-1380
[10]   Clinical features and outcome of community-onset bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli [J].
Kang, C. -I. ;
Cheong, H. S. ;
Chung, D. R. ;
Peck, K. R. ;
Song, J. -H. ;
Oh, M. -D. ;
Choe, K. -W. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2008, 27 (01) :85-88